Hypoxia-inducible factors and adenosine signaling in vascular growth

Extracellular ATP and Adenosine as Regulators of Endothelial Cell Function: Implications for Health and Disease

Volumn , Issue , 2010, Pages 113-124

  Ahmad, Aftab ^a   White, Carl W ^a   Ahmad, Shama ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

A2A receptor; A2B receptor; adenosine; Adenosine deaminase; Angiogenesis; ATP; CD39; CD73; DFO (desferrioxamine); DMOG (dimethyloxalylglycine); Endothelial cells; HIF 1 ; HIF 2 ; Hypoxia inducible transcription factors; Prolyl 4 hydroxylases; Vascular growth; VEGF; VEGFR 1; VEGFR 2; VHL (von Hippel Lindau tumor suppressor gene product)

Indexed keywords

EID: 84900043802     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-3435-9_7     Document Type: Chapter

References (74)

1. Adair TH. (2004) An emerging role for adenosine in angiogenesis. Hypertension 44:618-20.
2. Adair TH. (2005) Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 289:R283-96.
3. Ahmad A, Ahmad S, Glover L, Miller S, Shannon JM, Guo X, Franklin WA, Bridges JP, Schaack JB, Colgan SP, White CW. (2009) Adenosine A (2A) receptor is a unique angiogenic target of HIF-2β in pulmonary endothelial cells. Proc Natl Acad Sci USA 106:10684-9.
4. Ahmad S, Ahmad A, White CW. (2006) Purinergic signaling and kinase activation for survival in pulmonary oxidative stress and disease. Free Radic Biol Med 41:29-40.
5. Aird WC. (2008) Endothelium in health and disease. Pharmacol Rep 60:139-43.
6. Asikainen TM, Ahmad A, Schneider BK, Ho WB, Arend M, Brenner M, Gunzler V, White CW. (2005) Stimulation of HIF-1alpha, HIF-2alpha, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells. Free Radic Biol Med 38:1002-13.
7. Banerjee SK, Young HW, Barczak A, Erle DJ, Blackburn MR. (2004) Abnormal alveolar development associated with elevated adenine nucleosides. Am J Respir Cell Mol Biol 30:38-50.
8. Bruns RF. (1980) Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can J Physiol Pharmacol 58:673-91.
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-9.
10. Cassada DC, Tribble CG, Laubach VE, Nguyen BN, Rieger JM, Linden J, Kaza AK, Long SM, Kron IL, Kern JA. (2001) An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. J Vasc Surg 34:482-8.
11. Chen H, Yang D, Carroll SH, Eltzschig HK, Ravid K. (2009) Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury. Exp Hematol 37:533-8.
12. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, Van De Rijn M, Botstein D, Brown PO. (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 100:10623-8.
13. Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH, Ratcliffe PJ, Maher ER. (2001) Contrasting effects on HIF-1alpha regulation by diseasecausing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 10:1029-38.
14. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P. (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8:702-10.
15. Daly JW, Padgett WL. (1992) Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase. Biochem Pharmacol 43:1089-93.
16. Desai A, Victor-Vega C, Gadangi S, Montesinos MC, Chu CC, Cronstein BN. (2005) Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol 67:1406-13.
17. Duan LJ, Zhang-Benoit Y, Fong GH. (2005) Endothelium-intrinsic requirement for Hif-2alpha during vascular development. Circulation 111:2227-32.
18. Dubey RK, Gillespie DG, Jackson EK. (2002) A (2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 39:530-5.
19. 2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118:3301-15.
20. Eltzschig HK, Kohler D, Eckle T, Kong T, Robson SC, Colgan SP. (2009) Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113:224-32.
21. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, Loffler M, Reyes G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP. (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202:1493-505.
22. Ethier MF, Dobson JG, Jr. (1997) Adenosine stimulation of DNA synthesis in human endothelial cells. Am J Physiol 272:H1470-9.
23. Ethier MF, Chander V, Dobson JG, Jr. (1993) Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 265:H131-8.
24. 2B and A3 adenosine receptors. Circ Res 92:485-92.
25. 2B receptors in angiogenic factor regulation. Circ Res 90:531-8.
26. 2B angiogenic phenotype. Hypertension 44:649-54.
27. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-42.
28. Fong GH, Rossant J, Gertsenstein M, Breitman ML. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
29. Gorlach A. (2005) Control of adenosine transport by hypoxia. Circ Res 97:1-3.
30. Grant MB, Davis MI, Caballero S, Feoktistov I, Biaggioni I, Belardinelli L. (2001) Proliferation, migration, and ERK activation in human retinal endothelial cells through A (2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci 42:2068-73.
31. Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC, Belardinelli L. (1999) Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 85:699-706.
32. Gu JW, Brady AL, Anand V, Moore MC, Kelly WC, Adair TH. (1999) Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells. Am J Physiol 277:H595-602.
33. Gu JW, Ito BR, Sartin A, Frascogna N, Moore M, Adair TH. (2000) Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts. Am J Physiol Heart Circ Physiol 279:H2116-23.
34. Ham J, Rees DA. (2008) The adenosine a2b receptor: its role in inflammation. Endocr Metab Immune Disord Drug Targets 8:244-54.
35. Hashimoto E, Kage K, Ogita T, Nakaoka T, Matsuoka R, Kira Y. (1994) Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun 204:318-24.
36. Huang NK. (2003) Adenosine A2A receptors regulate oxidative stress formation in rat pheochromocytoma PC12 cells during serum deprivation. Neurosci Lett 350:127-31.
37. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-62.
38. King J, Hamil T, Creighton J, Wu S, Bhat P, McDonald F, Stevens T. (2004) Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 67:139-51.
39. Koditz J, Nesper J, Wottawa M, Stiehl DP, Camenisch G, Franke C, Myllyharju J, Wenger RH, Katschinski DM. (2007) Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 110:3610-7.
40. 2B receptor in hypoxia. Faseb J 20:2242-50.
41. Langenkamp E, Molema G. (2009) Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer. Cell Tissue Res 335:205-22.
42. Lasley RD, Jahania MS, Mentzer RM, Jr. (2001) Beneficial effects of adenosine A (2a) agonist CGS-21680 in infarcted and stunned porcine myocardium. Am J Physiol Heart Circ Physiol 280:H1660-6.
43. Leibovich SJ, Chen JF, Pinhal-Enfield G, Belem PC, Elson G, Rosania A, Ramanathan M, Montesinos C, Jacobson M, Schwarzschild MA, Fink JS, Cronstein B. (2002) Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A (2A) receptor agonists and endotoxin. Am J Pathol 160:2231-44.
44. Lutty GA, Mathews MK, Merges C, McLeod DS. (1998) Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr Eye Res 17:594-607.
45. Martin PL. (1999) Adenosine agonists for the prevention of restenosis? IDrugs 2:44-51.
46. McPherson JA, Barringhaus KG, Bishop GG, Sanders JM, Rieger JM, Hesselbacher SE, Gimple LW, Powers ER, Macdonald T, Sullivan G, Linden J, Sarembock IJ. (2001) Adenosine A (2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 21:791-6.
47. Meininger CJ, Schelling ME, Granger HJ. (1988) Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 255:H554-62.
48. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, Borea PA. (2006) Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. Biochem Pharmacol 72:19-31.
49. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, MacLennan S, Baraldi PG, Borea PA. (2005) A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells. Neoplasia 7:894-903.
50. Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O, Kawauchi S, Ema M, Shibahara S, Udono T, Tomita K, Tamai M, Sogawa K, Yamamoto M, Fujii-Kuriyama Y. (2003) HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 22:1134-46.
51. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK. (2008) HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111:5571-80.
52. Muller CE, Scior T. (1993) Adenosine receptors and their modulators. Pharm Acta Helv 68:77-111.
53. 2B receptor-mediated posttranscriptional mechanism. J Immunol 175:8260-70.
54. Ohta A, Sitkovsky M. (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916-20.
55. Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP. (2000) A (2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279:F809-18.
56. Olanrewaju HA, Qin W, Feoktistov I, Scemama JL, Mustafa SJ. (2000) Adenosine A (2A) and A (2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 279:H650-56.
57. Palmer TM, Stiles GL. (1997) Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry 36:832-8.
58. Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM. (2006) Stromal derived factor-1. (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer 5:56.
59. Peirce SM, Skalak TC, Rieger JM, Macdonald TL, Linden J. (2001) Selective A (2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am J Physiol Heart Circ Physiol 281:H67-74.
60. Peng J, Zhang L, Drysdale L, Fong GH. (2000) The transcription factor EPAS-1/hypoxiainducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA 97:8386-91.
61. Pueyo ME, Chen Y, D'Angelo G, Michel JB. (1998) Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. Exp Cell Res 238:354-8.
62. Ross SD, Tribble CG, Linden J, Gangemi JJ, Lanpher BC, Wang AY, Kron IL. (1999) Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J Heart Lung Transplant 18:994-1002.
63. Ryzhov S, McCaleb JL, Goldstein AE, Biaggioni I, Feoktistov I. (2007) Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia. J Pharmacol Exp Ther 320:565-72.
64. Ryzhov S, Zaynagetdinov R, Goldstein AE, Matafonov A, Biaggioni I, Feoktistov I. (2009) Differential role of the carboxy-terminus of the A (2B) adenosine receptor in stimulation of adenylate cyclase, phospholipase Cbeta, and interleukin-8. Purinergic Signal 5:289-98.
65. Schultz K, Murthy V, Tatro JB, Beasley D. (2009) Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms. Am J Physiol Lung Cell Mol Physiol 296:L921-7.
66. Scortegagna M, Morris MA, Oktay Y, Bennett M, Garcia JA. (2003) The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 102:1634-40.
67. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
68. Stevens T, Phan S, Frid MG, Alvarez D, Herzog E, Stenmark KR. (2008) Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts. Proc Am Thorac Soc 5:783-91.
69. Sun CN, Cheng HC, Chou JL, Lee SY, Lin YW, Lai HL, Chen HM, Chern Y. (2006) Rescue of p53 blockage by the A (2A) adenosine receptor via a novel interacting protein, translinassociated protein X. Mol Pharmacol 70:454-66.
70. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP. (2002) Ecto-5'-nucleotidase. (CD73) regulation by hypoxiainducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110:993-1002.
71. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP. (1996) Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37:2165-76.
72. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. (1998) The hypoxiaresponsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12:3320-4.
73. Trincavelli ML, Falleni A, Chelli B, Tuscano D, Costa B, Gremigni V, Lucacchini A, Martini C. (2003) A (2A) adenosine receptor ligands and proinflammatory cytokines induce PC 12 cell death through apoptosis. Biochem Pharmacol 66:1953-62.
74. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. (2003) Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxiainducible factor-alpha. J Biol Chem 278:15911-6.